BENLYSTA
BENLYSTA (belimumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, helping to protect healthy cells from damage. Specifically, it is a B-lymphocyte stimulator. BENLYSTA is used together with other lupus medicines to treat active systemic lupus erythematosus (SLE).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
What it treats
Systemic Lupus
Prescribed by
Rheumatologists
How it’s administered
Intravenous (IV) infusion
or subcutaneous injection
Frequency
Every two weeks for three doses,
then every four weeks
Length of treatment
About an hour